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Minimally Invasive or Abdominal Radical Hysterectomy
for Cervical Cancer
To the Editor: In the trial reported by Ramirez
et al. (Nov. 15 issue),1 the authors observed lower
survival rates among women with early-stage
cervical cancer who underwent minimally invasive surgery than among those who underwent
open surgery. These results suggest that factors
such as CO2 gas insufflation might cause early
spread of tumor cells, which in turn compromises outcomes. Similar findings were observed in
the accompanying retrospective study conducted
by Melamed et al.2
We tested the replicability of these findings
in patients with other pelvic cancers, using selection criteria and methods similar to those used
by Melamed et al. Our inverse probability of
treatment–weighted analysis (involving 3928 patients with data in the National Cancer Database
in the period 2010–2011) showed that patients
who underwent cystectomy by means of minimally invasive surgery had similar 4-year mortality as their counterparts who underwent open
surgery (45.7% and 45.9%, respectively; P = 0.07).
Likewise, our interrupted time-series analysis
(with the use of data from the Surveillance, Epidemiology, and End Results [SEER] 18-registry
database for the 2000–2010 period) showed no
significant change in trend in 4-year relative
survival among patients who underwent cystectomy before the adoption of minimally invasive
surgery (i.e., in years 2000–2003; −0.3%; 95%
confidence interval [CI], −2.5 to 1.2)3 as compared with those who underwent surgery after
2003 (1.5%; 95% CI, 0.6 to 2.4) (P = 0.20 for
trend). Similar results were observed in patients
who underwent prostatectomy (data not shown),
which suggests that the findings reported regarding cervical cancer may not be generalizable
to all pelvic cancers.
n engl j med 380;8
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To the Editor: The unexpected results of the
trial conducted by Ramirez et al. have brought a
great debate within the academic arena. Under
the umbrella of the European Society of Gynecological Oncology (ESGO), we recently conducted
a survey entitled “after LACC [Laparoscopic Approach to Cervical Cancer] trial,” which had 400
responses. We found that 83% of the survey respondents did not anticipate these trial results.
Respondents attributed the outcomes in the minimally invasive surgery group to several factors,
such as a less radical technique than with open
surgery, incorrect manipulation, and spread of
the tumor because of CO2 gas insufflation. A total of 57% of the ESGO members who responded
to the survey have changed their approach to
open surgery, and 50% consider minimally invasive surgery to be appropriate only for small tumors. Almost 90% of the respondents reported
that they intend to share this article with every
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patient, and 75% consider it unethical not to discuss the trial results with surgical candidates.
The results of this trial are now on the table,
but the final conclusions regarding its effect have
to be elucidated. It is time to discover why minimally invasive surgery has done so poorly and, if
possible, how to improve it.
Luis Chiva, M.D., Ph.D.
Clinica Universidad de Navarra
Madrid, Spain
lchiva@unav.es
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We found similar results for the same subgroup of patients when we used the tumor–
node–metastasis classification. Whether the use
of a uterine manipulator is a factor for recurrence remains to be determined.
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To the Editor: On the basis of the results of the
LACC trial conducted by Ramirez et al. and the
National Cancer Database report from Melamed
et al., we performed a subanalysis of our recently
published results,1 including only the population
with the highest risk of recurrence (stages IB1
through IIA1, according to the FIGO [International Federation of Gynecology and Obstetrics]
2009 criteria, with tumors measuring 2 to 4 cm
in the greatest dimension), and the data are presented here. No uterine manipulators were routinely used. Instead, a vaginal probe was used to
delineate the vaginal fornices.
Of 111 patients, 57 underwent minimally invasive surgery (laparoscopic or robotic) and 54
underwent laparotomy. The rates of lymphovascular invasion (46% and 45%, respectively) and
positive nodes (16% and 18%) were similar in
the two groups. With a median follow-up of
8.6 years, there were no differences between the
minimally invasive surgery group and the laparotomy group in rates of recurrence (14% and
17%, respectively; P = 0.69), cancer-specific survival (calculated from the date of surgery to the
date of death from cervical cancer or last followup; 88% and 87%, P = 0.77), disease-free survival
(calculated from the date of surgery to the date
of first recurrence or last follow-up in patients
without relapse; 86% and 77%, P = 0.34), and
overall survival (88% and 78%, P = 0.20).
794
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Drs. Ramirez and Obermair reply: Chiva et al.
comment on the ESGO survey that was conducted after the results of our randomized trial were
presented at the Society of Gynecologic Oncology
meeting in March 2018. It should be highlighted
that this survey was conducted before the final
publication of our article. Nevertheless, they
found on the basis of preliminary data that 57%
of the respondents had switched from minimally
invasive to open radical hysterectomy. The respondents attributed outcomes in the minimally
invasive surgery group to less radical technique
and incorrect uterine manipulation. In our trial,
the open-surgery group and the minimally invasive surgery group were balanced for histologic
subtype, grade, stage, tumor size, and lymphnode status. In addition, there was no significant
difference in parametrial involvement or vaginal
margins, which thus argues against inadequate
radicality in the minimally invasive surgery group.
The survey also pointed to the issue of incorrect uterine manipulation. Clearly, this is a subjective observation and more a commentary than
a scientific fact, given that there are no data as
to what defines adequate uterine manipulation.
Pertaining to tumor dissemination and effect of
CO2 gas insufflation on tumor implantation, we
agree with this hypothesis1 and discuss it in our
article. We are encouraged to learn that 90% of
the respondents planned on sharing the results
of our trial with patients. It would be interesting
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to see results from this same survey being conducted after the final publication of the article.
In response to Gil-Moreno and Magrina: our
prospective, randomized trial was not designed
to determine the cause of the inferior outcomes
observed in the minimally invasive surgery group.
The concept that a uterine manipulator is a potential factor that may increase the risk of recurrence is speculative. The results presented by their
group in this correspondence are based on a
retrospective comparison of a very small cohort
of patients.2 Such comparisons highlight the
flaws of retrospective sequential comparisons
with limited numbers of patients. The groups
that were compared may not be balanced with
regard to selection of the patients, risk factors,
adjuvant therapy, surveillance strategies, or documentation and confirmation of recurrences. In
addition, in retrospective data, the duration of
follow-up ought to be evaluated for each group,
given that there is usually shorter follow-up in
the minimally invasive surgery group than in the
open-surgery group, thus leading to a lower likelihood of time allowed for the manifestation of
recurrent events. The reported recurrence rate of
14% in their minimally invasive surgery group
far exceeds that of the same approach in our
prospective trial (8.4%).
Pedro T. Ramirez, M.D.
M.D. Anderson Cancer Center
Houston, TX
peramire@mdanderson.org
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Dr. Melamed and coauthors reply: Abdollah
and colleagues note that the increased risk of
death related to minimally invasive radical hysterectomy that was observed in our study may not
be generalizable to other operations for pelvic
cancers. Two randomized trials have shown the
oncologic safety of minimally invasive hysterecn engl j med 380;8

tomy for endometrial carcinoma.1,2 Furthermore,
our observational study3 showed that minimally
invasive staging surgery for epithelial ovarian
cancer was not associated with shorter survival
than laparotomy. The safety and effectiveness of
minimally invasive surgery must be evaluated independently for specific oncologic indications
whenever feasible. Extrapolation of study findings across anatomical locations, histologic types,
and tumor stages should be undertaken with extreme caution.
The comments of Gil-Moreno and Magrina
present an opportunity to address the limitations of small, retrospective studies that compare the risk of recurrence and death between
minimally invasive surgery and open radical
hysterectomy for cervical cancer. With only 111
patients and a recurrence rate of approximately
16%, the progression-free survival estimates reported by Gil-Moreno and Magrina are based on
no more than 17 recurrences. As such, their study
is severely underpowered. Furthermore, the small
number of events makes adjustment for multiple
confounders challenging. The absence of a significant difference in rates of recurrence and
survival reported by Gil-Moreno and Magrina,
and in studies of similar design, is likely to be
due to the limitations inherent to the study design. Interpreting these findings as strong evidence in support of the safety of minimally invasive radical hysterectomy for cervical cancer is
imprudent.
Alexander Melamed, M.D., M.P.H.
Massachusetts General Hospital
Boston, MA
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